Walking Can Lower Risk of Heart-Related Conditions Equal To Running

Apr. 12 | According to surprising findings reported in the American Heart Association journal Arteriosclerosis, Thrombosis and Vascular Biology, walking briskly can lower your risk of high blood pressure, high cholesterol and diabetes as much as running can. Researchers...

FDA Approved Aegerion Pharmaceutical’s Juxtapid

Jan. 2 | The U.S. Food and Drug Administration (FDA) approved Juxtapid (lomitapide) to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol, apolipoprotein B, and non-high-density lipoprotein (non-HDL) cholesterol in patients with homozygous familial...

Investigational Amgen Drug Slashed Cholesterol By 81 Percent

Apr. 20 | Amgen announced about the positive results from a Phase 1b clinical study of AMG 145, an investigational PCSK9 inhibitor, in patients with high cholesterol who were taking statins. The study demonstrated that multiple doses of AMG 145 significantly reduced...